ATAI Life Sciences Analyst Ratings
Buy Rating Affirmed for ATAI Life Sciences Amid Promising TRD Treatment Developments and Strategic Growth Potential
Analysts Offer Insights on Healthcare Companies: Athira Pharma (ATHA), Celcuity (CELC) and ATAI Life Sciences (ATAI)
ATAI Life Sciences Analyst Ratings
Atai Life Sciences Upgraded at Maxim on Beckley Investment
ATAI Life Sciences Analyst Ratings
ATAI Life Sciences Analyst Ratings
Buy Rating Affirmed for ATAI Life Sciences on Promising TRD Treatment Trial Outcomes and Strong Valuation Prospects
Analysts Offer Insights on Healthcare Companies: ATAI Life Sciences (ATAI), Halozyme (HALO) and Natera (NTRA)
HC Wainwright & Co. Reiterates Buy on ATAI Life Sciences, Maintains $20 Price Target
ATAI Life Sciences Analyst Ratings
Buy Rating Affirmed for ATAI Life Sciences on Strong Clinical Data and Positive Valuation Outlook
HC Wainwright & Co. Reiterates Buy on ATAI Life Sciences, Maintains $20 Price Target
ATAI Life Sciences Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: ATAI Life Sciences (ATAI), Guardant Health (GH)
ATAI Life Sciences (ATAI) Gets a Buy From TD Cowen
Analysts Offer Insights on Healthcare Companies: Cross Country Healthcare (CCRN), ATAI Life Sciences (ATAI) and Ionis Pharmaceuticals (IONS)
Analysts Are Bullish on These Healthcare Stocks: MoonLake Immunotherapeutics (MLTX), ATAI Life Sciences (ATAI)
HC Wainwright & Co. Reiterates Buy on ATAI Life Sciences, Maintains $20 Price Target
ATAI Life Sciences Analyst Ratings
No Data